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CHAPTER 1 -USE OF ANTIMICROBIAL PROPHYLAXIS DURING SURGERY
The use of peri-operative antibiotics to decrease the incidence of surgical-site infections (SSI) has been well established. [1] [2] [3] [4] [5] [6] Antimicrobials are recommended in procedures associated with high risk of infection or when postoperative infection would have catastrophic consequences on the outcome of surgery. 3, [7] [8] [9] In humans and animals, SSI can be a devastating complication, prolong the length of hospital stay and dramatically increase medical costs. 5, 10, 11 There are some important concepts associated with the use of antimicrobial prophylaxis and they will be discussed in this report.
Surgical Site Infections
There is conflicting evidence of the efficacy of prophylactic antimicrobials in veterinary medicine, with some studies 12 showing no effect and other studies showing a decrease in the incidence of SSI for routine clean surgical procedures. 3, 13 A randomized blinded prospective controlled study showed that the infection rate for control dogs was significantly higher (15.7%) than the rate for dogs treated with peri-operative antimicrobials (3.8%). 3 In another study, 347 of 365 dogs (95.3%) that underwent orthopedic surgery received peri-operative antibiotics. Five of 347 (0.01%) developed SSI, whereas 3 of 16 (18.7%) that did not receive peri-operative antibiotic developed SSI. 13 Other studies have shown an overall infection rate between 5.9% and 8.9% for a variety of clean and clean-contaminated procedures with a conclusion that prophylaxis was not required for these procedures. [14] [15] [16] Bacterial drug resistance (including multi-drug resistant bacteria), increased risk of hospital-acquired infection, and increased cost of the medical care are possible consequences of inappropriate or indiscriminate use of antimicrobials. 1, 15, [17] [18] [19] A study in humans showed that antimicrobial prophylaxis was often not consistent with local or national guidelines; redosing schedule was followed at an appropriate time only in 40% of the cases but improved to 68% with an automatic reminder system. 20 A different study in humans from a tertiary teaching hospital found that only 3 per cent of the procedures received an appropriate medication, dose, duration and redose timing according to the hospital guidelines. 19 Similarly, dogs undergoing orthopedic surgery showed discrepancies between standard recommendations and the antimicrobial prophylaxis used. Sixteen per cent of the dogs did not receive the drug within 60 minutes of surgery, 19% received unnecessary repeated doses and 49% received additional doses at an incorrect time. 15 Multiple studies have shown that the timing of antibiotic administration and redosing schedule are not always performed according to the institution guidelines. One study found that 78% of dogs received the first antimicrobial dose before surgery; out of these dogs 84% received the dose within 60 minutes of the first incision. Twelve percent of dogs were initially treated during surgery, 10 to 165 minutes after the first incision. If a guideline of repeated administration every 90 minutes after the first administration until closure of the surgical-site was used, 51%
dogs received the required intraoperative administration, and 19% of dogs that did not require intraoperative dosing were treated. 12 A more recent study showed a redosing incidence of 93.5%, which they considered excellent; however, 28.4% of dogs received antimicrobials late, with the dose being administered more than 30 minutes late in 28% of those dogs.
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Antibiotic Selection
The antibiotic selected for prophylactic use must be effective against the pathogen most likely to cause postoperative wound infection. 3, 7, 8 Antibiotics with efficacy against commonly encountered pathogens, such as Staphylococcus spp., Streptococcus spp. and sometimes Escherichia coli, are usually recommended in veterinary medicine based on the location of the surgery. In order for antimicrobial prophylaxis to be effective, it must be present at the surgicalsite at an adequate concentration before the time of contamination and throughout the surgical procedure. 6-8, 22, 23 Cephalosporins are effective antimicrobials, well tolerated, and obtain targeted serum and tissue concentrations. 9 Cefazolin has been recommended as the ideal prophylactic antibiotic for surgery in dogs and has become one of the most common antimicrobials for peri-operative use because of its spectrum, low incidence of adverse effects, and low cost. 3, 7, 8, 24 The beta-lactam antimicrobials (penicillins and cephalosporins) are time-dependent, meaning that efficacy is correlated with the time that drug concentration remains above the minimum inhibitory concentration (MIC) for a particular pathogen. 7, 25 Based on pharmacokinetic studies it has been recommended for time-dependent antimicrobials such as beta-lactams to be redosed intraoperatively every 2 half-lives in order to maintain targeted plasma concentrations. 7, 8, 12, 24 Cefazolin is not appreciably absorbed after oral administration and must be given parenterally to achieve therapeutic serum levels. 
Antibiotic Interstitial Fluid Concentration
Protein binding is a major factor in the tissue distribution of a drug. 22 In order to predict antimicrobial activity, it is important to know the concentration of the protein-unbound antimicrobial at the site of bacterial contamination (surgical-site). A previous study has suggested that the concentration of cefazolin in the ISF is similar to plasma due to rapid equilibration of cefazolin between serum and soft tissues in the surgical wound. The concentration of antibacterial agents in the interstitial tissue fluid has been studied in an experimental model using implanted perforated Silastic capsules (tissue cages). The lining within the cage contains young fibroblasts, many capillaries, and obvious tissue spaces. The rate of diffusion into and out of the cage fluid of small molecules, such as sodium, is rapid, whereas for larger molecules, such as albumin, it is slower. [27] [28] [29] These tissue cages, however, need to be implanted 4 weeks prior to the sampling collection to allow ingrowth of cells into the cages and production of interstitial fluid.
On the other hand, some researchers have used ultrafiltration. Ultrafiltration provides a means for collecting protein-unbound cefazolin in the ISF by use of an implanted semipermeable membrane in the tissue. Previous studies [30] [31] [32] have shown that an ultrafiltration device is a reliable and convenient method for collecting ISF samples from tissues in dogs. This device has become the preferred method for collecting ISF, rather than collection of tissue biopsy specimens or use of tissue cages, because of anatomic and physiologic relevance, lack of contamination from intracellular content, ease of insertion, the ability to collect serial samples with the same device, and monitoring of drug distribution in unrestrained animals. Furthermore, the ultrafiltration device provides a convenient method for continuous sample collection without residual wounds or lesions after removal of the ultrafiltration probes.
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Pharmacokinetic Analysis
Reversed-phase gradient high performance liquid chromatography (HPLC) has become the preferred method for drug discovery and drug metabolism studies. 33 
CHAPTER 2 -PHARMACOKINETICS OF CEFAZOLIN FOR PROPHYLACTIC ADMINISTRATION TO DOGS
Introduction
It has been clearly established that perioperative administration of antimicrobials can decrease the incidence of SSIs. [1] [2] [3] [4] [5] [6] Antimicrobials are recommended for procedures associated with high risk of infection or when postoperative infection would have catastrophic consequences on the outcome of surgery. 3, [7] [8] [9] In humans and other animals, SSI can be a devastating complication, prolong the duration of hospital stay, and dramatically increase medical costs. 5, 10, 11 There is conflicting evidence about the efficacy of prophylactic administration of antimicrobials in veterinary medicine; one investigator detected no effect, 12 whereas other investigators detected a decrease in the incidence of SSI for routine clean surgical procedures. 3, 13 In a randomized blinded prospective controlled study, 3 readministration of the antimicrobial during surgery if the procedure is still ongoing after 2 halflives of the drug have passed; restriction of treatment to the duration of surgery or for 24 hours, except in certain situations (i.e., gross contamination or preexisting infection); and avoiding use of newer broad-spectrum antimicrobials. 12 In 1 study, 20 prophylactic administration of antimicrobials to humans was often not consistent with local or national guidelines because a redosing schedule was followed at an appropriate time in only 40% of the patients, although this improved to 68% when an automatic reminder system was used. In another study 19 9 Cefazolin has been recommended as the ideal prophylactic antimicrobial for surgery in dogs and has become one of the antimicrobials most commonly used perioperatively because of its spectrum, low incidence of adverse effects, and low cost. 3, 7, 8, 21 For antimicrobial prophylaxis to be effective, an adequate concentration of the drug must be present at the surgical site before the time of contamination and throughout the surgical procedure. [6] [7] [8] 22, 23 The -lactam antimicrobials (penicillins and cephalosporins) are timedependent drugs, which means that efficacy is correlated with the amount of time that drug concentration remain above the MIC for a particular pathogen. 7, 24 On the basis of results of pharmacokinetic studies, 7, 8, 12, 23 it has been recommended that time-dependent antimicrobials such as -lactams should be readministered every 2 half-lives during surgery to maintain targeted plasma concentrations.
In a previous study, 8 it was suggested that the concentration of cefazolin in the interstitial fluid is similar to the concentration in plasma owing to rapid equilibration of cefazolin between serum and soft tissues in a surgical wound. To our knowledge, the concentration of cefazolin in the surgical site has been measured and compared with serum concentrations (by obtaining muscle biopsy specimens and determining the antimicrobial concentration with a modified agar plate diffusion technique) in only 2 studies. 7, 22 However, tissue concentrations may underestimate true surgical site concentrations because the interstitial fluid is diluted with intracellular fluid. An ultrafiltration probe has been used to obtain interstitial fluid in other studies. [25] [26] [27] It has been found that this is a reliable, easily performed, and useful method for the evaluation of drug disposition in dogs, and it eliminates the need for collection of tissue samples or use of tissue cages to estimate concentrations in tissues.
The purpose of the study reported here was to compare the cefazolin concentration in interstitial fluid obtained from dogs receiving a single IV injection of cefazolin and dogs receiving simultaneous IV and IM injections of cefazolin. We hypothesized that the concentration in the interstitial fluid would be higher and more prolonged in the group receiving simultaneous IV and IM injections, compared with results for the group receiving only an IV injection.
Materials and Methods
Animals
Twelve purpose-bred Beagles (6 males and 6 females) were used in the study. All dogs were 1 year old and considered healthy; a physical examination, CBC, and serum biochemical profile were performed to verify health of the dogs. All dogs had an albumin concentration > 3.4
g/dL (range, 3.4 to 4.2 g/dL). All dogs were allowed to acclimatize to the environment before initiation of the study. The study was reviewed and approved by the Institutional Animal Care
and Use Committee at Kansas State University.
Implant placement
Dogs were sedated with dexmedetomidine hydrochloride a (15 g/kg, IV). An indwelling percutaneous catheter was placed in the jugular vein, and 2 ultrafiltration probes b were placed in the dorsum of each dog. The ultrafiltration probes contained 3 loops with a 12-cm semipermeable membrane. The semipermeable membrane in the loop consisted of pores that allowed water, electrolytes, and low-molecular-weight (< 30 KDa) molecules to diffuse across the membrane but excluded the passage of proteins, protein-bound drugs, and other highmolecular-weight compounds. For insertion of the ultrafiltration probes, an area (2.5 cm on each side of the midline at the dorsal caudolateral aspect of the scapulae) was shaved and aseptically prepared. One of the insertion sites was infused with a solution of 2% lidocaine hydrochloride c (1 mg/kg), a stab incision was made through the skin with a No. 11 scalpel blade, and subcutaneous tissues were identified. An introducer needle was inserted in the stab incision, advanced cranially through the subcutaneous tissues for a distance of 10 cm, and exited through the skin; the ultrafiltration probe was then threaded through the needle from a cranial to caudal direction (Figure1) until the tip of the probe was flush with the tip of the introducer needle. The introducer needle containing the probe was then retracted 3 cm so that the 3 loops of the probe remained under the skin in the interstitial space and the nonpermeable portion of the probe remained external to the dog's skin. The ultrafiltration probe was then secured to the skin with a non-absorbable nylon suture d by use of a finger-trap pattern. A vacuum-vial needle e was attached to the ultrafiltration probe tubing, and a collection tube was attached to that needle to apply negative pressure on the probe system for collection of interstitial fluid through the semipermeable membrane. The probe insertion procedure then was repeated for the opposite side. After the ultrafiltration probes were inserted, sedation was reversed by administration of atipamezole hydrochloride f (2.4 mg/kg, IM). The initial collection tubes were allowed to remain in place for ≥ 18 hours to equilibrate the system before the initiation of the study.
Experimental design
Dogs were assigned to 2 groups (6 dogs/group) by use of randomizing software. 
Sample collection
Interstitial fluid was collected in a microcentrifuge tube i inserted in a red top vacuum tube j before (time 0) and 1, 1.5, 2, 3, 4, and 5 hours after administration of cefazolin. Samples were immediately placed on ice. All samples subsequently were stored at -70° C until testing was performed.
UPLC-UV drug analysis
Concentrations 29 Values were considered significant at P < 0.05
Statistical analysis
Results
The IV group initially consisted of 3 males and 3 females; however, 1 male was removed from the study because the dog removed the ultrafiltration devices before the initiation of the sample collection period. Thus, data were collected for 5 dogs in the IV group (mean body weight, 8.7 kg; range, 7.4 to 10.8 kg). The IV + IM group consisted of 3 males and 3 females (mean body weight, 9.7 kg; range, 8.7 to 10.7 kg).
Mean concentrations of cefazolin in interstitial fluid were measured for both groups (Figure 2 ; Table 1 g/mL, respectively; P = 0.003) hours.
Comparing the mean values for pharmacokinetic parameters between the IV and IV + IM groups revealed a significant (P = 0.004) difference in AUCINF (74.99 and 154.16 h•g/mL, respectively; Table 2 ). In addition, the AUCINF was dose related. There was no significant difference between the IV and IV + IM groups for Cmax (37.3 and 51.5 g/mL, respectively), t1/2 (0.96 and 1.11 hours, respectively), and Tmax (1.28 and 1.65 hours, respectively).
Discussion
On the basis of results of the present study, we accepted the hypothesis that doubling the dose of cefazolin (22 mg/kg, IV, and 22 mg/kg, IM) adds 1 half-life to persistence of the drug.
Although not significant, the half-life was approximately 15% (approx. 10 minutes) longer for the IV + IM group, compared with the expected half-life if the IV dose had been doubled. There is a slightly longer drug exposure with every half-life. This slight increase in exposure time may be explained by a slower absorption rate when the drug is administered IM. After achieving equilibrium between the serum and interstitial fluid as a result of the IV injection of cefazolin, and given the constant elimination rate and low protein-binding capacity of the drug, the IM injection would increase the number of unbound molecules of cefazolin available for distribution for a longer period because of the higher total dose.
In the present study, we found that concentrations of cefazolin in interstitial fluid in all dogs were maintained above 4 g/mL for 4 hours after a single injection of cefazolin (22 Protein binding is a major factor for tissue distribution of a drug. 21 To predict antimicrobial activity, it is important to know the concentration of the protein-unbound antimicrobial at the site of bacterial contamination (surgical site). Ultrafiltration provides a means for collecting protein-unbound cefazolin in the interstitial fluid by implantation of a semipermeable membrane in the tissue. Investigators of other studies [25] [26] [27] have found that an ultrafiltration device is a reliable and convenient method for collecting interstitial fluid samples from tissues in dogs. This device has become the preferred method for collecting interstitial fluid, rather than collecting tissue biopsy specimens or using tissue cages, because of anatomic and physiologic relevance, lack of contamination from intracellular content, ease of insertion, collection of serial samples with the same device, and monitoring drug distribution in unrestrained animals. Furthermore, the ultrafiltration device provides a convenient method for continuous sample collection without residual wounds or lesions after removal of the ultrafiltration probes. 21 To our knowledge, the study reported here was the first in which an ultrafiltration probe was used to determine the cefazolin concentration in interstitial fluid. By use of this device, we were able to detect a biologically accurate concentration of cefazolin in what we anticipate will be equivalent to the tissue biophase or surgical site, rather than in serum, which is a critical factor for determining the efficacy of agents used for prophylaxis against SSIs. 30 Timing of antibiotic administration and redosing schedules are not always in accordance with institution guidelines. In 1 study, 12 investigators found that 78% of dogs received the first antimicrobial dose before surgery; however, only 84% of those dogs received the dose within 60 minutes before the first incision. Twelve percent of dogs were initially treated during surgery (10 to 165 minutes after the first incision). 12 If a guideline of repeated administration every 90 minutes after the first administration until closure of the surgical site were used, 51% of dogs received the required intraoperative administration, and 19% of dogs that did not require intraoperative administration were treated. 12 In a more recent study, 23 investigators found a redosing incidence of 93.5%, which they considered excellent; however, 28.4% of dogs received antimicrobials late, with the dose being administered more than 30 minutes late in 28% of those dogs. In the study reported here, administration of cefazolin (22 mg/kg, IV, and 22 mg/kg, IM)
before surgery results in antimicrobial concentrations that should be adequate against the most common skin contaminants for surgical procedures expected to last ≤ 4 hours, and a redosing schedule would not be necessary.
The bacteria most commonly involved in SSIs in dogs and cats are commensal organisms on the skin (gram-positive cocci) and normal flora from the gastrointestinal and other tracts (predominantly gram-negative rods), depending on the surgical procedure. 15, 31 Historically, it has been recommended that time-dependent antimicrobials such as -lactams be readministered during surgery every 2 half-lives to maintain therapeutic concentrations during surgery. 7, 8, 12, 23 Investigators of other studies have reported that the MIC90 is 0.25 to 2 g/mL for S pseudintermedius, 7,32,33 4 g/mL for Streptococcus spp, 32,33 and 16 g/mL for E coli. 7, 24 A more recent study 34 of E coli revealed an MIC that inhibited 75% of isolates was 4 g/mL and the MIC90 was 128 g/mL. It should be considered that although isolates were collected from 33 infection sites in that study, 34 approximately 70% of the isolates were from the urinary tract, with the ear being a distant second (7.2% of isolates), and no other body system providing more than 4% of isolates. These isolates may have been exposed to various courses of antimicrobials prior to isolation (i.e., recurrent urinary tract and otic infections) and may not be representative of bacteria that would typically be found in surgical patients.
The present study had some limitations. We were unable to determine pharmacokinetic parameters of cefazolin in serum because of presumed contamination of the percutaneous catheter with cefazolin during IV administration (data not included). Even if the drug residual in the catheter was 0.1%, it would have biased the data substantially. Injection of the cefazolin and collection of blood samples were through the same catheter; therefore, the measured concentration of the drug in serum was not accurate, especially at early time points. Although we did not determine the pharmacokinetic parameters of cefazolin in serum, this information can be obtained from other studies. 2, 7, 22, 30 Furthermore, the primary site of interest in the present study was interstitial fluid. The AUC for serum after administration of a dose of 40 mg/kg is 192.5 h•g/mL (11,548 g•min/mL), and t1/2 is 1.26 hours (75.8 minutes). 22 The AUC for serum after administration of a dose of 20 mg/kg is 135.9 h•g/mL (8,158 g•min/mL), and t1/2 is 0.91 hours (5.08 minutes). 7 Investigators of another study 30 Tables   Table 1 -Mean, minimum, and maximum concentrations of cefazolin (g/kg) in interstitial fluid after administration of a single dose (22 mg/kg, IV) to 5 dogs (IV group) and simultaneous IV and IM administration (22 mg/kg, IV, and 22 mg/kg, IM) to 6 dogs (IV + IM group). 
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